Published in Cancer Weekly, March 23rd, 2010
Taro's fluorouracil cream is a prescription pharmaceutical product used for topical treatment of multiple actinic or solar keratoses and superficial basal cell carcinomas, and is bioequivalent to Efudex® Topical Cream 5% of Valeant Pharmaceuticals International. According to industry sources, Efudex® Topical Cream 5% had annual U.S. sales in 2009 of approximately $70 million.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.